COMMON QUESTIONS
Kisspeptin: your questions, answered.
Direct, cited answers to the questions people actually ask about kisspeptin — mechanism, fertility, PCOS, isoforms and pharmacology.
What is the link between kisspeptin and PCOS?
Serum kisspeptin runs high in PCOS. A meta-analysis of nine studies (n=1,282) found it significantly higher in women with PCOS than controls (standardized mean difference 0.57, 95% CI 0.32-0.82), correlating with LH, testosterone and leptin [8]. Overactive kisspeptin signaling is thought to help drive the excess LH and androgen output, making it a candidate PCOS biomarker [9].
Are kisspeptin levels elevated in PCOS?
Yes, in most studied cohorts. The pooled meta-analysis showed significantly elevated serum kisspeptin in PCOS (SMD 0.57, 95% CI 0.32-0.82) [8], and a focused review found the elevation most prominent in PCOS phenotypes with high LH [9]. The pattern is consistent enough that kisspeptin is studied as a PCOS biomarker, though the association is correlational, not causal proof.
Does kisspeptin trigger ovulation?
It can trigger the egg-maturation step in IVF. In a Phase 2 trial of 60 women at high OHSS risk, subcutaneous kisspeptin-54 (3.2-12.8 nmol/kg) triggered oocyte maturation in 95% of women with no moderate-to-critical OHSS; the highest live-birth rate (62%) followed the 9.6 nmol/kg dose [5]. It works by prompting the body's own LH surge rather than imposing a long-acting drug.
What is kisspeptin?
Kisspeptin is a neuropeptide encoded by the KISS1 gene and the principal upstream activator of GnRH neurons — the brain cells that pace reproduction. Genetic proof: loss-of-function mutations in its receptor GPR54 (KISS1R) cause failure of puberty in humans, and knockout mice reproduce the phenotype, establishing kisspeptin-GPR54 signaling as essential for reproductive maturation [1].
What does kisspeptin do?
It switches on the reproductive hormone cascade. Kisspeptin binds KISS1R on hypothalamic neurons and triggers pulsatile GnRH release, which drives LH and FSH from the pituitary and downstream sex steroids [1]. It acts upstream — on the body's own GnRH neurons — and is not itself a sex hormone. Take its receptor away and puberty never starts [1].
Does kisspeptin increase testosterone?
In men, yes, indirectly via LH. Intravenous kisspeptin-10 raised LH from 4.1 to 12.4 IU/L within 30 minutes at a 1 µg/kg bolus in healthy men; a higher 4 µg/kg/h continuous infusion raised serum testosterone from 16.6 to 24.0 nmol/L [3]. It does not supply testosterone directly — it prompts the body's own LH, which stimulates testosterone production.
How much does kisspeptin increase testosterone?
In the main healthy-men study, a 4 µg/kg/h continuous intravenous infusion of kisspeptin-10 raised serum testosterone from 16.6 to 24.0 nmol/L, alongside increased LH and LH pulse frequency [3]. This is a research finding in a supervised setting, reported as the dose and population studied — not a dosing recommendation, and the response is subject to tachyphylaxis with sustained exposure.
What is kisspeptin used for in research?
Mainly reproductive research. A 2025 systematic review counted 29 interventional trials spanning secondary amenorrhea, puberty regulation, ovarian function, trophoblast invasion, fertility regulation, parturition and lactation [7]. Its strongest results are as an IVF oocyte-maturation trigger and in restoring LH pulsatility in hypothalamic amenorrhea. No kisspeptin product is approved for any indication [7].
Can kisspeptin help with fertility?
In research, it shows two fertility-relevant effects. As an IVF trigger, subcutaneous kisspeptin-54 matured eggs in 95% of high-OHSS-risk women with no severe OHSS and a 62% live-birth rate at the optimal dose [5]. In hypothalamic amenorrhea it restored ovulatory LH rhythm [4]. It remains investigational, not an approved fertility treatment, and these are supervised study findings.
Can kisspeptin restore ovulation in women with hypothalamic amenorrhea?
It can restore the underlying LH rhythm. Continuous intravenous kisspeptin-54 (0.01-1.00 nmol/kg/h) raised LH pulses from 1.6 to 5.0 per 8 hours (about three-fold) and pulse mass from 3.92 to 23.44 IU/L (about six-fold) versus vehicle in affected women [4]. The highest dose produced tachyphylaxis, so the response depends heavily on dose and timing rather than amount [4].
What is the difference between kisspeptin-10 and kisspeptin-54?
Length and duration. Kisspeptin-10 is the 10-residue C-terminal fragment and clears fast — a functional half-life of roughly 4 minutes in humans. Kisspeptin-54 is the full 54-residue form (originally "metastin"), more resistant to breakdown, with a half-life of about 27-28 minutes [5]. The longer kisspeptin-54 is favored where a steadier signal is wanted, such as the IVF trigger and amenorrhea infusions [4].
What is the KISS1 gene?
KISS1 is the gene (on chromosome 1q32) that encodes the kisspeptin family. It was discovered in 1996 as a metastasis-suppressor gene, then reframed in 2003 when GPR54 (its receptor) mutations were shown to cause failure of puberty, establishing the KISS1/kisspeptin system as the master upstream regulator of reproduction [1]. Its product is the principal activator of GnRH neurons.
What is metastin and how does it relate to kisspeptin?
Metastin is the original name for kisspeptin-54, given when KISS1 was identified as a metastasis-suppressor gene in melanoma — the gene's protein product appeared to suppress tumor spread [11]. "Metastin" and "kisspeptin-54" now refer to the same 54-residue peptide; the reproductive role came later, after GPR54 was linked to puberty [1].
How was kisspeptin discovered?
In two stages. KISS1 was found in 1996 as a metastasis-suppressor gene in human melanoma, named for Hershey, Pennsylvania. Its orphan receptor GPR54 was matched to kisspeptin around 2001, and in 2003 loss-of-function GPR54 mutations were shown to cause hypogonadotropic hypogonadism and failure of puberty — recasting kisspeptin as the reproductive axis's master switch [1].
What receptor does kisspeptin bind?
Kisspeptin binds KISS1R, formerly called GPR54 (and historically hOT7T175 or AXOR12), a Gq/11-coupled G-protein-coupled receptor on hypothalamic GnRH neurons. Loss-of-function mutations in this receptor cause failure of puberty; activation drives a calcium cascade that fires the neuron and releases GnRH [1]. The receptor's centrality is why it is the keystone of the kisspeptin story.
How does kisspeptin work in the body?
It triggers a relay. Kisspeptin binds KISS1R on GnRH neurons, setting off a phospholipase C / IP3 / calcium cascade that depolarizes and fires the neuron, releasing GnRH in pulses [2]. GnRH then drives LH and FSH from the pituitary, which stimulate the sex steroids [1]. Kisspeptin works on your own neurons upstream of GnRH — it supplies no hormone itself.
How long does kisspeptin take to work?
Hormonally, fast. Intravenous kisspeptin-10 produced maximal LH stimulation within about 30 minutes in healthy men (LH 4.1 to 12.4 IU/L at a 1 µg/kg bolus) [3]. The response is acute because the peptide acts directly on GnRH neurons; kisspeptin-10's short half-life (~4 minutes) means its action is brief, while kisspeptin-54 sustains a longer signal [3].
What is the half-life of kisspeptin?
It depends on the form. Kisspeptin-10 has a functional half-life of roughly 4 minutes in humans because plasma peptidases clear it quickly. Kisspeptin-54 lasts longer, about 27-28 minutes, owing to its larger size and greater resistance to enzymatic cleavage [5]. That difference is why kisspeptin-54 is preferred where a more sustained hormonal signal is needed.
What is the mechanism by which kisspeptin-10 exerts its effects?
Kisspeptin-10 binds KISS1R (GPR54) on GnRH neurons and activates a Gq/11 / phospholipase C / IP3 cascade that releases intracellular calcium, closing potassium channels and opening cation channels to depolarize the neuron [2]. In adult GnRH neurons, 100 nM kisspeptin depolarized cells by 6 ± 1 mV and raised firing by 87 ± 4% [2], driving pulsatile GnRH and downstream LH/FSH release.
How does stress suppress kisspeptin and disrupt the reproductive axis?
Stress and low energy availability suppress the GnRH pulse generator, and kisspeptin neuron activity falls with it — the picture seen in functional hypothalamic amenorrhea. Related work points to reduced neurokinin B (a regulator of kisspeptin release), significantly lower in affected women, as a contributing factor [12]. Restoring kisspeptin signaling can revive the LH rhythm in this setting [4].
How does kisspeptin reduce OHSS risk compared to hCG as an IVF trigger?
By triggering a short, self-limiting surge instead of a long hormonal drive. In 60 high-OHSS-risk women, subcutaneous kisspeptin-54 matured eggs in 95% with no moderate, severe or critical OHSS at any dose [5]. Because kisspeptin prompts the body's own brief LH release rather than supplying a long-acting trigger, it avoids the prolonged over-stimulation that raises OHSS risk [5].
Can kisspeptin-54 trigger ovulation more safely than GnRH agonists in IVF?
The trial evidence is encouraging on safety. Subcutaneous kisspeptin-54 triggered oocyte maturation in 95% of high-risk women with zero moderate-to-critical OHSS and a 62% live-birth rate at the optimal 9.6 nmol/kg dose [5]. Kisspeptin acts upstream of GnRH on the body's own neurons; the data position it as a potentially safer oocyte-maturation trigger, though it remains investigational and unapproved [7].